Nifedipine Interaction with Tacrolimus in Liver Transplant Recipients

Abstract

Spanish

French

OBJECTIVE:

To examine the possible drug interaction between nifedipine and tacrolimus in liver transplant recipients.

STUDY DESIGN:

A retrospective study was done comparing two groups of liver transplant recipients. The starting time for comparison was the same after transplant. One group (n = 22) consisted of hypertensive patients who were treated with nifedipine; the other group (n = 28) did not receive nifedipine. The two groups were compared over 1 year. The effect of nifedipine on tacrolimus was measured in terms of tacrolimus whole blood trough concentrations, daily tacrolimus dosages, and cumulative tacrolimus dosages at 1, 3, 6, and 12 months. All patient charts were reviewed with regard to concurrent medication that could affect the metabolism of tacrolimus and eventually affect tacrolimus concentrations and dosages.

DATA COLLECTION:

All required information was retrieved from medical records.

RESULTS:

There was a statistically significant difference between daily dosage requirements of tacrolimus at 90 (p = 0.03), 180 (p = 0.004), and 365 (p = 0.0004) days between the nifedipine and no-nifedipine groups. The tacrolimus daily dosage in the nifedipine group was decreased by 26%, 29%, and 38% at 3, 6, and 12 months, respectively, compared with the dosage of the no-nifedipine group. Statistically significant differences in cumulative dosages of tacrolimus were observed at 180 (p = 0.02) and 365 (p = 0.003) days between the nifedipine and no-nifedipine groups, with cumulative dosage reduction of 25% and 31% by 6 and 12 months, respectively, in the nifedipine group compared with the no-nifedipine group.

CONCLUSIONS:

Nifedipine decreased the daily and cumulative dosage requirement of tacrolimus. The interaction observed between nifedipine and tacrolimus is the first reported in humans and is clinically important. As a result of this drug interaction, it is recommended that blood concentrations of tacrolimus be monitored during coadministration of these drugs and that the tacrolimus dosage be adjusted accordingly.

Keywords

nifedipine tacrolimus drug interactions transplantation

Get full access to this article

View all access options for this article.

References

Klintmalm

. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110–5.

Williams

. Randomized trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 1994; 334: 423–8.

Knight

Kerman

Welsh

Golden

Schoenberg

Van Buren

. Chronic rejection in primary renal allograft recipients under cyclosporine prednisone immunosuppressive therapy. Transplantation 1991; 51: 355–9.

Vincent

Karanam

Painter

Chiu

. In vitro metabolism of FK506 in rat, rabbit, and human liver microsomes: Identification of a major metabolite and of cytochrome P-450 3A as the major enzymes responsible for its metabolism. Arch Biochem Biophys 1992; 294: 454–60.

Sattler

Guengerich

Yun

Christians

Swing

. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos 1992; 20: 753–61.

Stiff

Venkataramanan

Orasad

TNV

. Metabolism of FK506 in differentially induced rat liver microsomes. Res Commun Chem Pathol Pharmacol 1992; 78: 121–4.

Christians

Braun

Schmidt

Kosian

Schiebel

Ernst

. Specific and sensitive measurement of FK506 and its metabolites in blood and urine of liver graft recipients. Clin Chem 1992; 38: 2025–32.

Miniscalco

Lundahl

Regardh

Edgar

Eriksson

. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 1992; 261: 1195–9.

Wagner

Henkel

Heinemeyer

Neumayer

. Interaction of calcium blockers and cyclosporine. Transplant Proc 1988; 20 (suppl 2):561–8.

10.

Henricsson

Lindholm

. Inhibition of cyclosporine metabolism by other drugs in vitro. Transplant Proc 1988; 20: 569–71.

11.

Kiberd

. Cyclosporine induced renal dysfunction in human renal allograft recipients. Transplantation 1989; 48: 965–9.

12.

McNally

Mistry

Idle

Walls

Feehally

. Calcium channel blockers and cyclosporine metabolism. Transplantation 1989: 48: 1071.

13.

Propper

Whiting

Power

Edward

Catto

. The effect of nifedipine on graft function in renal allograft recipients treated with cyclosporine A. Clin Nephrol 1989; 32: 62–7.

14.

Sketris

Methot

Nicol

Belitsky

Knox

. Effects of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients. Ann Pharmacother 1994; 28: 1227–31.

15.

Iwasaki

Matsuda

Nagase

Shiraga

Tokuma

Uchida

. Effects of twenty three drugs on the metabolism of FK506 by human liver microsomes. Res Commun Chem Pathol Pharmacol 1993; 82: 209–16.

16.

Seifeldin

Marcos-Alvarez

Lewis

Gordon

Jenkins

. Effect of nifedipine on renal function in liver transplant recipients receiving tacrolimus. Clin Ther 1996; 18: 491–6.